Saturday 17 October 2026 Export BNGO’s income statement to Excel — free account

Bionano Genomics, Inc.

BNGO Healthcare Medical Instruments & Supplies

Bionano Genomics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.5 million, down 7.37% from fiscal 2024. In the quarter to June 2026, revenue grew 21.4%, EPS grew 67.8%, free cash flow fell 33.9% and total debt fell 1.91%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.25 0.12 −8.76%

Follow BNGO

Alert me

Market cap: $16.1M
P/E: 0.0×
Fwd P/E: −0.6×
Dividend yield: —
F-score: 5/9
Altman Z: −14.26
Beneish M: −3.39
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	5	5	5	5
ROE Full definition →		(78.22%)	(66.15%)	(73.78%)	(83.56%)
ROA Full definition →		(46.37%)	(35.13%)	(44.12%)	(52.04%)
ROIC Full definition →		(107.08%)	(113.43%)	(126.00%)	(81.68%)
Return on Tangible Assets Full definition →		(91.88%)	(70.78%)	(99.40%)	(115.46%)
Average Days of Receivables Full definition →		57.52	66.58	52.49	52.81
Free Cash Flow per Share Full definition →		(3.50)	(3.00)	(1.76)	(1.77)
Free Cash Flow Full definition →		(18.67)	(16.34)	(19.30)	(20.48)
Other line items
Cash ROIC Full definition →		(21.93%)	(21.11%)	(29.42%)	(45.04%)
Accounts Receivable Turnover Full definition →		5.84	5.73	7.68	7.68
Accounts Payable Turnover Full definition →		2.11	2.44	2.62	2.93
Inventory Turnover Full definition →		1.45	1.85	2.05	2.29
Average Days of Payables Full definition →		140.89	133.16	121.24	105.12
Days of Inventory on Hand Full definition →		165.80	129.77	127.11	119.87
Tax Rate Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		40.46%	39.90%	42.25%	40.43%
Selling, General and Administrative Expense of Revenue Full definition →		132.97%	123.30%	118.75%	113.75%
Share Based Compensation of Revenue Full definition →		19.30%	15.90%	12.59%	11.62%
Operating CF/Net income Full definition →		0.48	0.62	0.61	0.64
Depreciation/Fixed assets Full definition →		0.59	0.59	0.62	0.67
Capex/Depreciation Full definition →		0.00	0.00	0.00	0.00
Revenue per Share Full definition →		5.38	5.24	2.62	2.61
Operating CF per Share Full definition →		(3.50)	(3.00)	(1.76)	(1.77)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00

Fold the line items

Columns are period end dates

Stockrow Weekly